ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 183 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 4.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $131 | -98.0% | 11,678 | -92.8% | 0.00% | -100.0% |
| Q1 2023 | $6,580 | -18.8% | 162,694 | -6.7% | 0.00% | 0.0% |
| Q4 2022 | $8,108 | -99.9% | 174,303 | -27.6% | 0.00% | -50.0% |
| Q3 2022 | $12,485,000 | +40.2% | 240,687 | +27.8% | 0.00% | +100.0% |
| Q2 2022 | $8,903,000 | -35.2% | 188,343 | -2.4% | 0.00% | 0.0% |
| Q1 2022 | $13,742,000 | -33.0% | 193,059 | -29.6% | 0.00% | -50.0% |
| Q4 2021 | $20,513,000 | +37.8% | 274,317 | +4.7% | 0.00% | +100.0% |
| Q3 2021 | $14,891,000 | +33.9% | 262,123 | +3.7% | 0.00% | 0.0% |
| Q2 2021 | $11,125,000 | -73.9% | 252,782 | -70.8% | 0.00% | -75.0% |
| Q1 2021 | $42,625,000 | +5.3% | 864,261 | -10.1% | 0.00% | 0.0% |
| Q4 2020 | $40,477,000 | -9.3% | 961,445 | -1.3% | 0.00% | -20.0% |
| Q3 2020 | $44,609,000 | -30.7% | 974,429 | -24.0% | 0.01% | -37.5% |
| Q2 2020 | $64,397,000 | -7.6% | 1,282,557 | -5.3% | 0.01% | -27.3% |
| Q1 2020 | $69,684,000 | -19.2% | 1,354,938 | -3.0% | 0.01% | 0.0% |
| Q4 2019 | $86,266,000 | -7.7% | 1,396,335 | -10.2% | 0.01% | -15.4% |
| Q3 2019 | $93,440,000 | -27.6% | 1,555,252 | +1.7% | 0.01% | -27.8% |
| Q2 2019 | $128,978,000 | -1.4% | 1,528,541 | +11.7% | 0.02% | -5.3% |
| Q1 2019 | $130,770,000 | +72.0% | 1,369,037 | +27.5% | 0.02% | +46.2% |
| Q4 2018 | $76,030,000 | -16.3% | 1,073,422 | +1.0% | 0.01% | 0.0% |
| Q3 2018 | $90,851,000 | -8.4% | 1,063,084 | +24.3% | 0.01% | -13.3% |
| Q2 2018 | $99,151,000 | +284.9% | 855,491 | +168.7% | 0.02% | +275.0% |
| Q1 2018 | $25,762,000 | +18.0% | 318,404 | -14.4% | 0.00% | 0.0% |
| Q4 2017 | $21,830,000 | +355.4% | 372,010 | +263.1% | 0.00% | +300.0% |
| Q3 2017 | $4,794,000 | – | 102,444 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 476,042 | $45,472,000 | 12.29% |
| Stonepine Capital Management, LLC | 60,840 | $5,811,000 | 3.34% |
| ACUTA CAPITAL PARTNERS, LLC | 61,000 | $5,827,000 | 2.77% |
| Virtus ETF Advisers LLC | 10,634 | $1,016,000 | 2.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $5,827,000 | 2.15% |
| ARMISTICE CAPITAL, LLC | 372,000 | $35,533,000 | 1.94% |
| Matarin Capital Management, LLC | 209,403 | $20,002,000 | 1.46% |
| Monashee Investment Management LLC | 50,000 | $4,776,000 | 1.10% |
| Granahan Investment Management | 151,322 | $14,454,000 | 0.78% |
| ALGERT GLOBAL LLC | 13,186 | $1,260,000 | 0.72% |